8-KItem 5.02 · Officer/Director ChangeItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Dexcom appoints former Stryker CFO Glenn Boehnlein to its board
Filed with the SEC on · Summarized by InvestorsBot
Dexcom appointed Glenn Boehnlein to its Board of Directors effective September 10, 2026. Boehnlein served as Stryker’s vice president and CFO from 2016 to 2025 and brings experience in financial leadership, capital allocation, strategic M&A, and medical technology operations; he also serves on the boards of Inogen and Agilent Technologies.